Exploration of the potential mechanism of Pushen capsule in the treatment of vascular dementia based on network pharmacology and experimental verification. (15th November 2022)

• Record Type: Journal Article
• Authors: Liu, Yun; Li, Shuo; Liu, Dandan; Wei, Hong; Wang, Xingzhi; Yan, Fuling
• Is Part Of: Journal of ethnopharmacology. Volume 298(2022)
• Publication Date: 2022-11-15
• Subjects: Pushen capsule -- Vascular dementia -- Network pharmacology -- Experimental verification -- Neuroinflammation; ANOVA analysis of variance -- Arg-1 arginase-1 -- CBF cerebral blood flow -- CCH chronic cerebral hypoperfusion -- ELISA Enzyme linked immunosorbent assay -- GAPDH glyceraldehyde-3-phosphate dehydrogenase -- GFAP glial fibrillary acidic protein -- Iba-1 ionized calcium binding adaptor molecule-1 -- IL-1β interleukin-1beta -- IL-6 interleukin-6 -- MWM Morris water maze -- NORT novel object recognition test -- qRT-PCR Quantitative real-time PCR -- rUCCAO right unilateral common carotid artery occlusion -- SEM standard error of mean -- TCM Traditional Chinese medicines -- TNF-α tumor necrosis factor-alpha -- VaD vascular dementia -- VaMCI vascular mild cognitive impairment -- DL drug likeness -- GO Gene Ontology -- KEGG Kyoto Encyclopedia of Genes and Genomes -- OB oral bioavailability; Ethnopharmacology -- Periodicals; Pharmacognosy -- Periodicals; Herbs -- Periodicals; Herbs -- Periodicals; Pharmacognosy -- Periodicals; Pharmacognosie -- Périodiques; Herbes -- Périodiques; 615.1
• DOI: 10.1016/j.jep.2022.115632
• Languages: English
• ISSNs: 0378-8741

Abstract

Abstract: Headings ethnopharmacological relevance: Pushen capsule is a traditional Chinese medicine compound functioning as 'stimulating blood circulation to remove blood stasis', which widely used to treat hyperlipidemia. Recent clinical research showed that Pushen capsule ameliorated cognitive function in patients with vascular mild cognitive impairment. Aim of the study: Explore the potential mechanism of Pushen capsule in vascular dementia (VaD) using network pharmacology analysis and experimental verification. Materials and methods: Active ingredients and their related targets of Pushen capsule, and VaD-related targets were searched in public databases. Core targets, potential functions and mechanisms of Pushen capsule on VaD were predicted by protein-protein interaction (PPI), Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. In vivo experiments were conducted to demonstrate the potential mechanisms of Pushen capsule in the treatment of VaD. Results: In total, 155 active ingredients, 273 related targets of Pushen capsule, and 1035 VaD-related targets were selected from the public databases. 147 common targets of Pushen capsule against VaD were obtained. The PPI network, GO and KEGG enrichment analyses revealed that some core targets and signaling pathways are related to inflammation. The experimental results showed that Pushen capsule treatment largely alleviated hippocampal glial activation, accelerated the polarization of activated microglia from the M1 to the M2 phenotype and reduced associated inflammatory factor expression to protect against VaD-induced neuronal loss, synaptic protein reduction and cognitive defects in a dose-dependent manner. Moreover, Pushen capsule reduced the mRNA expression of NF-κB p65; and STAT1. Conclusion: Our study demonstrates that Pushen capsule alleviates hippocampal neuroinflammation to protect against VaD-induced cognitive impairment in a dose-dependent manner. The neuroprotective effect of Pushen capsule on VaD might be regulated by the NF-κB; and JAK-STAT pathway. Graphical abstract: Image 1